| Dr Bryan Douglas Maxwell, DO | |
|
9 Healthcare Dr, Biddeford, ME 04005-9449 | |
| (207) 282-4270 | |
| (207) 294-8332 |
| Full Name | Dr Bryan Douglas Maxwell |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 9 Healthcare Dr, Biddeford, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477521482 | NPI | - | NPPES |
| 010092761 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | DO3418 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Rmh Medical Center | Harrisonburg, VA | Hospital |
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-atlantic Womens Care Plc | 8820998156 | 140 |
| Mainehealth | 7517860588 | 2067 |
News Archive
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.
ResCare, Inc. announced today that it has entered into a definitive agreement with an entity sponsored by Onex Partners III, L.P. ("Onex"), an affiliate of Onex Corporation. Under the terms of the agreement, Onex would acquire all of the outstanding shares of ResCare common stock not owned by Onex affiliates or participating members of ResCare's management for $13.25 per share in cash, which represents a 30.7% premium to the closing price on August 13, 2010, the last trading day before Onex made its initial proposal.
UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.
› Verified 2 days ago
| Entity Name | Mid-atlantic Womens Care Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699365072 PECOS PAC ID: 8820998156 Enrollment ID: O20040115000607 |
News Archive
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.
ResCare, Inc. announced today that it has entered into a definitive agreement with an entity sponsored by Onex Partners III, L.P. ("Onex"), an affiliate of Onex Corporation. Under the terms of the agreement, Onex would acquire all of the outstanding shares of ResCare common stock not owned by Onex affiliates or participating members of ResCare's management for $13.25 per share in cash, which represents a 30.7% premium to the closing price on August 13, 2010, the last trading day before Onex made its initial proposal.
UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.
› Verified 2 days ago
| Entity Name | Harrisonburg Ob Gyn Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942388939 PECOS PAC ID: 5890710065 Enrollment ID: O20051007000176 |
News Archive
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.
ResCare, Inc. announced today that it has entered into a definitive agreement with an entity sponsored by Onex Partners III, L.P. ("Onex"), an affiliate of Onex Corporation. Under the terms of the agreement, Onex would acquire all of the outstanding shares of ResCare common stock not owned by Onex affiliates or participating members of ResCare's management for $13.25 per share in cash, which represents a 30.7% premium to the closing price on August 13, 2010, the last trading day before Onex made its initial proposal.
UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.
› Verified 2 days ago
| Entity Name | Mid-atlantic Womens Care Plc |
|---|---|
| Entity Type | Part B Supplier - Mammography Center |
| Entity Identifiers | NPI Number: 1699365072 PECOS PAC ID: 8820998156 Enrollment ID: O20080611000246 |
News Archive
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.
ResCare, Inc. announced today that it has entered into a definitive agreement with an entity sponsored by Onex Partners III, L.P. ("Onex"), an affiliate of Onex Corporation. Under the terms of the agreement, Onex would acquire all of the outstanding shares of ResCare common stock not owned by Onex affiliates or participating members of ResCare's management for $13.25 per share in cash, which represents a 30.7% premium to the closing price on August 13, 2010, the last trading day before Onex made its initial proposal.
UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bryan Douglas Maxwell, DO 9 Healthcare Dr, Biddeford, ME 04005-9449 Ph: (207) 282-4270 | Dr Bryan Douglas Maxwell, DO 9 Healthcare Dr, Biddeford, ME 04005-9449 Ph: (207) 282-4270 |
News Archive
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.
ResCare, Inc. announced today that it has entered into a definitive agreement with an entity sponsored by Onex Partners III, L.P. ("Onex"), an affiliate of Onex Corporation. Under the terms of the agreement, Onex would acquire all of the outstanding shares of ResCare common stock not owned by Onex affiliates or participating members of ResCare's management for $13.25 per share in cash, which represents a 30.7% premium to the closing price on August 13, 2010, the last trading day before Onex made its initial proposal.
UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.
› Verified 2 days ago
Tammi Bittler, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9 Healthcare Drive, Suite 101, Biddeford, ME 04005 Phone: 207-282-4270 Fax: 207-282-7350 | |
Mary O'hare, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Drive, Suite 101, Biddeford, ME 04005 Phone: 207-282-4270 Fax: 207-282-7350 | |
Wayne White, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr, Biddeford, ME 04005 Phone: 207-282-4270 Fax: 207-282-7350 | |
Dr. Gretchen F Paranya, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr, Suite 101, Biddeford, ME 04005 Phone: 207-282-4270 Fax: 207-282-7350 | |
Gregory A Van Gundy, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9 Healthcare Drive, Suite 101, Biddeford, ME 04005 Phone: 207-282-4270 Fax: 207-282-7350 | |
Peter C Manning, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Drive, Suite 101, Biddeford, ME 04005 Phone: 207-282-4270 Fax: 207-282-4270 |